Navigating Paths With Uncertain Destinations: A Phenomenological Exploration of Decision Making on Disease-Modifying Therapies in Multiple Sclerosis
Qualitative Health Research · 19.11.2026
DOI: 10.1177/10497323261492958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Qualitative Health Research, online erschienen am 19.11.2026. Verfasst von Eva C. van Reenen und 4 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Dutch National MS Foundation, Merck Group.
Abstract (Originalsprache)
People with relapsing-remitting multiple sclerosis (RRMS) face complex choices among various disease-modifying therapies (DMTs), each marked by uncertain outcomes. Shared decision making (SDM) is increasingly promoted to support such treatment decisions, yet how people experience choosing a DMT under inherent uncertainty within this context remains underexplored. This study examines how people with RRMS experience the initial choice for a DMT under inherent uncertainty within an SDM-framed healthcare context. A phenomenological-hermeneutic approach was adopted, involving interviews with 17 participants recently diagnosed with RRMS. Analysis reveals six experiential pathways: making the safer bet , facing confusion and disappointment , longing for clarity and understanding , constructing a narrative , relinquishing control , and putting in the work . Participants experience the decision as an arduous journey marked by fear, doubt, and responsibility. They grapple with ‘double uncertainty’ regarding both disease progression and treatment effectiveness. While SDM typically frames decision making as a rational weighing of evidence and preferences, participants experience treatment decisions as precarious, emotionally charged, and relationally embedded. Rather than eliminating uncertainty, they seek to reconcile with it by constructing narratives, trusting physicians, or surrendering to what cannot be controlled. These findings challenge a narrow view of SDM as a rational, individual act based on clear-cut evidence and stable preferences. They point to the need for a broader understanding of SDM as a relational, iterative practice, in which uncertainty is a moral and existential condition of care. This requires acknowledging uncertainty as part of care and supporting patients in integrating medical choices into meaningful, evolving life narratives.
Förderung
- Dutch National MS Foundation
- Merck Group
Zitieren
APA
Reenen, E. C. V., Essen, S. A. V., Niemeijer, A. R., Nistelrooij, I. A. M. V., & Visser, L. H. (2026). Navigating Paths With Uncertain Destinations: A Phenomenological Exploration of Decision Making on Disease-Modifying Therapies in Multiple Sclerosis. Qualitative Health Research. https://doi.org/10.1177/10497323261492958
Vancouver
Reenen ECV, Essen SAV, Niemeijer AR, Nistelrooij IAMV, Visser LH. Navigating Paths With Uncertain Destinations: A Phenomenological Exploration of Decision Making on Disease-Modifying Therapies in Multiple Sclerosis. Qualitative Health Research. 2026. doi:10.1177/10497323261492958
BibTeX
@article{Reenen2026,
author = {Reenen, Eva C. van and Essen, Steven A. van and Niemeijer, Alistair R. and Nistelrooij, Inge A. M. van and Visser, Leo H.},
title = {Navigating Paths With Uncertain Destinations: A Phenomenological Exploration of Decision Making on Disease-Modifying Therapies in Multiple Sclerosis},
journal = {Qualitative Health Research},
year = {2026},
doi = {10.1177/10497323261492958}
}
EUVIMED